Robert Kramer is VP at Emergent BioSolutions Inc. (EBS). They have made 9 open-market trades across 1 company since 2007, most recently 2023-06-09.
CIK 0001380956
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 364,520 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2023-06-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | SELL | 2021-02-08 | 2021-02-09 | $120.03 | $9.3M | -18.2% | -23.1% | -49.9% |
| EBS | SELL | 2021-01-20 | 2021-01-22 | $110.03 | $2.7M | +10.1% | -8.8% | -41.1% |
| EBS | SELL | 2021-01-15 | 2021-01-19 | $106.01 | $4.0M | -0.3% | +9.2% | -36.7% |
| EBS | SELL | 2016-04-06 | 2016-04-08 | $38.90 | $771K | -0.5% | -0.3% | -24.5% |
| EBS | SELL | 2016-04-06 | 2016-04-08 | $38.90 | $847K | -0.5% | -0.3% | -24.5% |
| EBS | SELL | 2016-04-04 | 2016-04-05 | $36.90 | $731K | +5.0% | +0.3% | -23.7% |
| EBS | SELL | 2016-04-04 | 2016-04-05 | $36.90 | $804K | +5.0% | +0.3% | -23.7% |
| EBS | SELL | 2016-04-01 | 2016-04-05 | $35.56 | $3.0M | +5.0% | +0.3% | -23.7% |
| EBS | SELL · 10b5-1 | 2014-11-07 | 2014-11-12 | $24.00 | $63K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2014-04-15 | 2014-04-17 | $24.34 | $1.2M | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2012-09-06 | 2012-09-10 | $14.82 | $415K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-28 | 2007-07-02 | $9.81 | $242K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-26 | 2007-06-28 | $9.47 | $241K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-22 | 2007-06-26 | $9.05 | $204K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-20 | 2007-06-22 | $9.19 | $187K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-18 | 2007-06-20 | $9.95 | $221K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-14 | 2007-06-18 | $8.96 | $202K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-12 | 2007-06-14 | $8.57 | $300K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-08 | 2007-06-12 | $8.62 | $172K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-06 | 2007-06-08 | $8.93 | $251K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-06-04 | 2007-06-06 | $9.61 | $270K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-05-31 | 2007-06-04 | $10.10 | $283K | -12.7% | -2.9% | -2.9% |
| EBS | SELL · 10b5-1 | 2007-05-29 | 2007-05-31 | $10.44 | $296K | -12.7% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.